Clinical Trial Update: Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy [Phase 1]

View source ↗

Summary

This Phase 1 trial update describes evaluating ropidoxuridine as a radiosensitizer in patients with advanced gastrointestinal cancers undergoing radiation thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Colon Cancer
• Esophageal Cancer
• Gastric Cancer
• Liver Cancer
• Pancreatic Cancer
• Rectal Cancer
• Small Intestinal Cancer

Drugs mentioned

• Ropidoxuridine (ropidoxuridine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Bile Duct Carcinoma, Stage II Esophageal Cancer AJCC v7 | Phase 1 | Status: ACTIVE_NOT_RECRUITING